amantadine has been researched along with scopolamine hydrobromide in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daniel Falcón, H | 1 |
| Barnett, A; Goldstein, JM; Malick, JB | 1 |
| Onodera, K; Shinoda, H | 1 |
| Maeda, N; Matsuoka, N; Yamaguchi, I | 1 |
| Messiha, FS | 1 |
| Amdur, RL; Carvey, PM; Kao, LC; Klawans, HL; Lin, DH; Singh, R; Zhang, TJ | 1 |
| Cashin, CH; Sutton, S | 1 |
| Papeschi, R; Randrup, A | 1 |
| Link, F | 1 |
| Manten, A | 1 |
| Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
1 review(s) available for amantadine and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for amantadine and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Collateral effects of antiparkinsonian agents used in psychiatry].
Topics: Amantadine; Antiparkinson Agents; Atropine; Atropine Derivatives; Benztropine; Brain; Histamine H1 Antagonists; Humans; Phenothiazines; Respiration; Scopolamine | 1976 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
Topics: Amantadine; Animals; Apomorphine; Brain; Denervation; Dopamine Agents; Dose-Response Relationship, Drug; Hippocampus; Male; N-Methylscopolamine; Neural Pathways; Parasympathetic Nervous System; Parasympathomimetics; Penile Erection; Pilocarpine; Rats; Scopolamine; Scopolamine Derivatives; Sulpiride | 1990 |
Gonadal alcohol and aldehyde dehydrogenase: in vivo and in vitro effects of psychoactive and endocrine agents.
Topics: Alcohol Dehydrogenase; Aldehyde Dehydrogenase; Amantadine; Animals; Chlorpromazine; Enkephalin, Leucine; Epididymis; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Papaverine; Psychotropic Drugs; Rats; Rats, Inbred Strains; Reserpine; Scopolamine; Species Specificity; Testis | 1990 |
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Lithium; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine; Stereotyped Behavior; Thioridazine | 1990 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Depression, Chemical; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Disulfides; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Humans; Hydrazines; Hypnotics and Sedatives; Male; Methyltyrosines; Motor Activity; Norepinephrine; Posture; Rats; Receptors, Drug; Scopolamine; Time Factors | 1973 |
[Chemotherapy of viral diseases].
Topics: Amantadine; Antiviral Agents; Atropine; Biguanides; Humans; Idoxuridine; Scopolamine; Thiosemicarbazones; Virus Diseases | 1967 |
[Chemoprofylaxis of influenza].
Topics: Amantadine; Animals; Antiviral Agents; Atropine; Biguanides; Humans; Influenza, Human; Mice; Scopolamine | 1968 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |